JAK1 inhibitors and uses thereof
US11931412B2 · kind B2 · utility
0Cited by
1References
29Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 4, 2021 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | May 25, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating pruritus having a neurogenic component in a subject in need thereof comprising administering a therapeutically effective amount of a JAK1 inhibitor based on a benzimidazole core, a purine core, or a pyrrolo pyridine core.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.